Vis enkel innførsel

dc.contributor.authorTroøyen, Susanne Hansen
dc.contributor.authorJacobsen, Elisabeth Egholm
dc.date.accessioned2023-02-15T09:58:50Z
dc.date.available2023-02-15T09:58:50Z
dc.date.created2023-01-05T13:06:07Z
dc.date.issued2022
dc.identifier.citationCatalysts. 2022, 12 (12), .en_US
dc.identifier.issn2073-4344
dc.identifier.urihttps://hdl.handle.net/11250/3050994
dc.description.abstractThe β-blocker (S)-betaxolol has been synthesized in 99% enantiomeric excess (ee) from the commercially available precursor 4-(2-hydroxyethyl)phenol. The racemic chlorohydrin 1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol was esterified with vinyl acetate catalyzed by lipase B from Candida antarctica, which gave the R-chlorhydrin (R)-1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol in 99% ee with 38% yield. The enantiomeric excess of the R-chlorohydrin was retained in an amination reaction with isopropylamine in methanol to yield (S)-betaxolol in 99% ee and with 9% overall yield. We are under way to improve the yield.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleChemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxololen_US
dc.title.alternativeChemo-Enzymatic Synthesis of Enantiopure β-Antagonist (S)-Betaxololen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber0en_US
dc.source.volume12en_US
dc.source.journalCatalystsen_US
dc.source.issue12en_US
dc.identifier.doi10.3390/catal12121645
dc.identifier.cristin2101293
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal